Medicine performance-enhancing specialists Nanoform announced it had completed a relative bioavailability study of its nanocrystalline enabled enzalutamide as an alternative to an amorphous solid dispersion formulation of Xtandi®, the leading prescribed androgen receptor inhibitor approved to treat prostate cancer.

Sanner, the healthcare packaging manufacturer and medical device CDMO has acquired Springboard, a specialist medical device designer and developer.

Sponsored by Expert Insights and Orientation Marketing, a panel of senior executives from the development and manufacturing partners charged with scaling and supplying medicines to patients were optimistic about 2024, but reflected on some of the challenges the industry will face too.

Brought to you by Orientation Marketing, hear thought-provoking views from five experienced c-level executives from leading development, technology, manufacturing, and bioprocessing partners.

Later, leaders from Sofinnova Investments, Blueprint Medicines, BioLineRx USA, and Dynavax should have a lively discussion about Independent Pathways to Commercial Success for Biotech Companies, and look out for the panel later on Oncology's Next Frontier, featuring speakers from Loxo@Lilly, Larkspur Bioscience, AbbVie, Merck Research Laboratories, and Abdera Therapeutics, which will cover antibody-drug conjugates (ADCs), Radiopharma, a and the future of cancer treatment.

Stephen J Ubl, president and chief executive officer of the Pharmaceutical Research and Manufacturers of America (PhRMA) will join Fierce for a Fireside chat. Ubl is known as a leading health care advocate and policy expert, and represents the U.S. biopharmaceutical industry, which employs more than 800,000 Americans and invests more than $100 billion each year in R&D.

Wednesday’s agenda opens with a keynote by Ken Keller, Chairman of the Board, President and Chief Executive Officer of Daiichi Sankyo, Inc., who uses his passion for innovation and compassion for patients as guiding principles of his leadership.

In A Look at Biopharma M&A and Shifting Deal Dynamics, industry leaders from Merck, Avenzo Theraputics and Astellas Pharma will examine the intricacies of biopharma transactions and a future of regulatory challenges and changed market forces.

The transformative impact of Artificial Intelligence (AI) on life sciences is indisputable. Join us on an exploration of AI’s potential within the pharmaceutical and healthcare industry. Hear two thought leaders discuss AI as a catalyst to create a more efficient and accessible healthcare future.

Look out for the keynote by Richard Francis, CEO of Teva Pharmaceuticals, where he’ll discuss how Teva’s focus on innovation, sustaining its generics powerhouse, and its focus on growth engines is fuelling the company’s Pivot to Growth Strategy to build a rich portfolio of innovative medicines.

At the CPHI Pharma Awards, CDMO Catalent scooped first place in the Supply Chain Excellence category. The company’s case management services provide professional end-to-end supply chain management and orchestration for autologous and allogeneic cell and gene therapies, and is designed to address the unique challenges associated with the safe and timely delivery of ATMPs. 

The Sanner Group announced the completion of the structural phase of its new headquarters and development and production site in Bensheim, Germany. The company will go on to fit out the site, and said it expects it will work closely with customers to move all production into the new facility by the beginning of 2025.

On the back of their 40th Anniversary event in Gamsen, Germany, Valsynthese posted their genuinely informative and entertaining short video that tells the company’s story from the perspective of its people.

Aptar Pharma showed off its newest innovations across nasal, pulmonary, eye care, injectables and dermal drug delivery routes, as well their digital health and active material science solutions.

To expedite product development and accelerate time-to-market, Colorcon announced its HyperStart C2C™ Smart Formulation Hub, which helps formulators minimize the need for repetitive formulation iterations.

Satatuote Oy, a specialist in providing plastic packaging solutions for pharmaceutical products and medical technology, recently announced how they have helped Sanofi reduce their use of transport packaging trays used in the manufacture of insulin pens.